A5031366166- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Diagnosis and Treatment of Venous Diseases
- Peripheral Artery Disease Management
- Central Venous Catheters and Hemodialysis
- Heparin-Induced Thrombocytopenia and Thrombosis
- Acute Ischemic Stroke Management
- Cerebrovascular and Carotid Artery Diseases
- Amyotrophic Lateral Sclerosis Research
- Intramuscular injections and effects
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Intracranial Aneurysms: Treatment and Complications
- Blood Pressure and Hypertension Studies
Centre Hospitalier Régional Universitaire de Brest
2022-2025
Université de Bretagne Occidentale
2022-2025
Inserm
2023-2025
Peripheral arterial dissections are uncommon, with cervical artery being the most prevalent type. Comparative data on evolution of renal, splanchnic, and coronary scarce. This study aimed to characterise assess prognosis non-aortic based their anatomical territories. Patients dissection cervical, coronary, or splanchnic arteries from 2017 - 2022 for which episode was documented at Nantes University Hospital were retrospectively included. A total 185 patients Compared other territories,...
Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease. Given the inflammatory nature of ALS and high number ALS-related clinical circumstances (eg, prolonged immobilization infections), patients with may have risk venous thromboembolism (VTE). To determine annual incidence rate VTE predictors in ALS. We analyzed prospective cohort diagnosed between 2009 2019 followed Brest University Hospital Centre. Among 227 ALS, occurred 19 during median follow-up period 717 days (IQR,...
Abstract Introduction The pathophysiology of residual pulmonary vascular obstruction (RPVO) and recurrent venous thromboembolism (VTE) after unprovoked embolism (PE) remains poorly understood. purpose was to evaluate fibrinolytic tissue remodeling markers as indicators RPVO recurrence a first PE. Methods Analyses were conducted in the 18 70-year-old patients included PADIS-PE trial, with (PVO) index ≥30% at PE diagnosis. After an initial six-month vitamin K antagonist treatment, randomised...
<b>Background:</b> In patients with cancer-associated thrombosis (CAT), knowledge on risk factors for recurrent venous thromboembolism (VTE) and clinically relevant bleeding (CRB) during anticoagulant therapy is sparse. <b>Aims:</b> To identify predictors of VTE CRB therapy. <b>Methods:</b> Cumulative incidences were evaluated in CAT from EDITH cohort using cumulative incidence functions (CIF) competing risks analysis cause-specific Fine-Gray models, considering as events interest death...